Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$3,922,820
+$642,680 QoQ
Shares Held
15,446
+15.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#1,789
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Charles Schwab Trust Co holds $19,134,040 across 8 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
31,692 | $7,974,974 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
15,446 | $3,922,820 | |
| 3 | AMGN |
Amgen Inc
|
7,464 | $2,702,863 | |
| 4 | LLY |
ELI LILLY & Co
|
1,832 | $2,197,355 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,250 | $1,060,125 | |
| 6 | BIIB |
Biogen Inc.
|
3,101 | $670,002 | |
| 7 | PFE |
Pfizer Inc
|
16,129 | $388,386 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,775 | $217,515 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,922,820 | 15,446 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $3,280,140 | 13,419 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $3,337,068 | 16,125 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,927,967 | 15,791 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $2,319,050 | 15,182 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,517,782 | 15,182 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,154,838 | 14,900 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,417,124 | 14,915 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,755,992 | 18,856 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,079,168 | 19,465 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $3,257,057 | 20,780 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,392,390 | 21,781 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,456,316 | 14,840 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,345,460 | 15,132 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $4,164,700 | 23,576 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $3,562,064 | 21,805 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,028,234 | 22,693 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $4,006,461 | 22,606 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $4,104,140 | 23,991 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $3,839,501 | 23,774 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $3,795,609 | 23,040 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $3,825,903 | 23,279 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,068,430 | 25,851 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $3,848,696 | 25,851 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $3,549,360 | 25,239 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $3,719,633 | 28,366 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||